5. EQUITY TRANSACTIONS (Tables)

9 Months Ended

12 Months Ended

Dec. 31, 2017

Mar. 31, 2017

Equity [Abstract]

Summary of warrant activity

	Amount			Range of Exercise Price	Weighted Average Exercise Price
Warrants outstanding at March 31, 2017		2,604,096		$2.10 - $12.05	$3.64
Exercised		(218,600	)	$1.10	$1.10
Issued		5,618,182		$1.10	$1.10
Cancelled/Expired		(139,357	)	$5.00 –$15.00	$6.52
Warrants outstanding at December 31, 2017		7,864,321		$1.10 - $12.05	$1.38
Warrants exercisable at December 31, 2017		7,864,321		$1.10 - $12.05	$1.38

	Fiscal Year Ended March 31,
	2017					2016
	Warrants			Weighted Average Exercise Price		Warrants			Weighted Average Exercise Price
Outstanding, beginning of year		2,164,094		$	6.68		1,430,738		$	6.84
Granted		749,825		$	4.10		746,657		$	6.30
Exercised		(2,660	)	$	6.25		(12,049	)	$	2.15
Cancelled/Forfeited		(307,163	)	$	5.18		(1,252	)	$	2.10
Outstanding, end of year		2,604,096		$	3.64		2,164,094		$	6.68
Exercisable, end of year		2,604,096		$	3.64		2,164,094		$	6.68
Weighted average estimated fair value of warrants granted				$	2.65				$	5.11

Assumptions used for warrants granted

Risk free interest rate	2.21%
Average expected life	10 years
Expected volatility	92.14%
Expected dividends	None

	Year Ended March 31,
	2017	2016
Risk free interest rate	0.7% - 1.93%	1.70%
Average expected life	3.42 – 5.5 years	5 years
Expected volatility	88.2% - 96.0%	98.6%
Expected dividends	None	None

Summary of warrant activity exercisable and outstanding

	Warrants Outstanding						Warrants Exercisable
Range of Exercise Prices	Number Outstanding		Weighted Average Remaining Life (Years)		Weighted Average Exercise Price		Number Outstanding		Weighted Average Exercise Price
$5.00 or Below		1,860,101		3.78	$	3.67		1,860,101	$	3.67
$5.20 - $9.00		711,067		2.77	$	6.47		705,067	$	6.47
$9.65 - $15.00		32,928		2.37	$	12.32		32,928	$	12.32
		2,604,096						2,604,096

Awards expected to vest

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Vested		432,047	$	10.98		3.64
Expected to vest		27,000	$	1.68		9.46
Total		459,047

	Number of RSUs
Vested		46,125
Expected to vest		507,375
Total		553,500

Summary of stock options outstanding

	Amount		Range of Exercise Price		Weighted Average Exercise Price
Stock options outstanding at March 31, 2017		432,047		$3.80-$20.50		$10.98
Exercised		–		–		–
Granted		27,000		$1.68		$1.68
Cancelled/Expired		–		–		–
Stock options outstanding at December 31, 2017		459,047		$1.68-$20.50		$10.44
Stock options exercisable at December 31, 2017		432,047		$3.80-$20.50		$10.98

	Fiscal Year Ended March 31,
	2017					2016
	Options			Weighted Average Exercise Price			Options			Weighted Average Exercise Price
Outstanding, beginning of year		438,547		$	10.94			501,690		$	11.00
Granted		–			N/A			–		$	N/A
Exercised		–			N/A			–		$	N/A
Cancelled/Forfeited		(6,500	)	$	7.96			(63,143	)	$	11.45
Outstanding, end of year		432,047		$	10.98			438,547		$	10.94
Exercisable, end of year		414,547		$	11.24			388,414		$	11.53
Weighted average estimated fair value of options granted					N/A					$	N/A

Detail of options outstanding and exercisable by exercise price

	Options Outstanding						Options Exercisable
Exercise Prices	Number Outstanding		Weighted Average Remaining Life (Years)		Weighted Average Exercise Price		Number Outstanding		Weighted Average Exercise Price
$3.80 - $9.50		184,047		6.70 years	$	6.82		166,547	$	6.86
$12.50		163,000		3.39 years	$	12.50		163,000	$	12.50
$18.00 - $20.50		85,000		1.02 years	$	19.03		85,000	$	19.03
		432,047						414,547

Schedule of stock-based compensation

	Three Months Ended December 31, 2017			Three Months Ended December 31, 2016			Nine Months Ended December 31, 2017			Nine Months Ended December 31, 2016
Vesting of stock options and restricted stock units	$	323,162		$	306,159		$	887,607		$	1,880,150
Total stock-based compensation expense	$	323,162		$	306,159		$	887,607		$	1,880,150
Weighted average number of common shares outstanding – basic and diluted		14,950,701			7,927,031			10,927,106			7,768,682
Basic and diluted loss per common share attributable to stock-based compensation expense	$	(0.02	)	$	(0.04	)	$	(0.08	)	$	(0.24	)

	Fiscal Year Ended
	March 31, 2017		March 31, 2016
Vesting of stock options	$	2,186,309	$	202,844
Total Stock-Based Compensation	$	2,186,309	$	202,844